Comparison of the Effects of Deep and Moderate Neuromuscular Blockade on Optic Nerve Sheath Diameter
MBLONDE
Comparison Of The Effects Of Deep And Moderate Neuromuscular Blockade On Optic Nerve Sheath Diameter İn Laparoscopic Cholecystectomy: A Randomized Controlled Trial
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Increased intracranial pressure (IICP) is a common problem in traumatic brain injuries and many medical diseases. Early recognition of IICP can save lives. Several invasive and non-invasive methods have been described for IICP diagnosis. In recent years, ultrasonographic measurement of optic nerve sheath diameter (ONSD) has become a popular method due to its high sensitivity and specificity for IICP estimation. Studies have shown that ONSD's ultrasonographic measurement correlates with the IICP and can detect intracranial hypertension. The ONSD measurement has advantages such as being easily applied by the clinician at the bedside, being non-invasive, providing immediate results, reproducibility and low cost. It is known that artificial carbon dioxide pneumoperitoneum created in laparoscopic surgeries increases intracranial pressure.However, it is not easy to estimate the degree of changes in ICP during laparoscopic surgery under general anesthesia. In the literature, there are many studies on the sonographic measurement of optic nerve sheath diameter to evaluate the effects of trendelenburg position on intracranial pressure with the use of different anesthetic drugs in laparoscopic surgeries. In addition, there are studies reporting that deep neuromuscular blockade in laparoscopic surgeries increases surgical vision and decreases analgesic requirement in postoperative period. The relationship between neuromuscular block level and intracranial pressure is not clear. From this point of view, the investigators would like to evaluate the effect of moderate and deep neuromuscular block level on intracranial pressure by sonographic measurement of optic nerve sheath diameter in laparoscopic cholecystectomy operations performed with standard pressure artificial carbon dioxide pneumoperitoneum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2019
CompletedFirst Posted
Study publicly available on registry
December 26, 2019
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedSeptember 13, 2021
September 1, 2021
4 months
December 4, 2019
September 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optic nerve sheath diameter
Sonographic optic nerve sheath measurements will be made 5 times, preoperatively, 5 minutes after endotracheal intubation, 5 minutes after pneumoperitoneum, 5 minutes after pneumoperitoneum is terminated and after extubation
During surgery
Secondary Outcomes (3)
Headache
24 hours
Postoperative nausea and vomiting score
24 hours
Patient satisfaction score
24 hours
Study Arms (2)
Deep neuromuscular block
OTHERPatients undergoing deep neuromuscular blockade with rocuronium (TOF -- PTC 1-5)
Moderate neuromuscular block
ACTIVE COMPARATORPatients undergoing moderate neuromuscular blockade with rocuronium (TOF 1-3)
Interventions
Optic nerve sheath diameter will be measured at both neuromuscular blocks level.
Deep neuromuscular block will be obtained via appropriate dose of rocuronium.
Moderate neuromuscular block will be obtained via appropriate dose of rocuronium.
Eligibility Criteria
You may qualify if:
- Between 18-65 years
- ASA I-II
- Patients undergoing elective laparoscopic cholecystectomy
You may not qualify if:
- Intracranial hypertension
- Glaucoma
- Chronic obstructive pulmonary disease
- Pseudotumor cerebri
- Cerebral venous sinus thrombosis
- İntraoperative hemodynamic instability
- Mean arterial blood pressure\<65 mmHg
- Body mass index\> 35
- Asthma
- Kidney or liver problems
- Lupus
- Crohn's disease or ulcerative colitis
- Previously had any gastrointestinal bleeding
- Hypertension
- Peripheral arterial disease
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serdar Yeşiltaş, Instructor
BEZMİALEM VAKIF UNIVERSITY
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The participants were blinded to group allocation, as the measurements were performed after induction of general anesthesia. The investigator measuring the optic nerve sheath diameter was blinded to the group assignment.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator, Medical Doctor, Anesthesiology and Reanimation
Study Record Dates
First Submitted
December 4, 2019
First Posted
December 26, 2019
Study Start
September 1, 2021
Primary Completion
January 1, 2022
Study Completion
February 1, 2022
Last Updated
September 13, 2021
Record last verified: 2021-09